Volume 4, Issue 2 (7-2006)                   IJRM 2006, 4(2): 77-80 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ghoraishian S M, Klantar S M, Seyed Hasani S M, Ghafourzadeh M. Comparison of Anticardiolipin antibody and Antiphospholipid antibody in women with recurrent abortions. IJRM 2006; 4 (2) :77-80
URL: http://ijrm.ir/article-1-50-en.html
Comparison of Anticardiolipin antibody and Antiphospholipid antibody in women with recurrent abortions
Seyed Mahmood Ghoraishian * , Seyed Mehdi Klantar , Seyed Mohammd Seyed Hasani , Mohammad Ghafourzadeh
Abstract:   (2127 Views)
Abstract
Recurrent abortion is a critical problem in which many factors play a crucial role such as anticordiolipin antibody and antiphospholipid antibody. This study was conducted to evaluate the frequency of anticardiolipin antibody and antiphospholipid antibody in pregnancy failures in women with the history of recurrent pregnancy loss. In 154 women with the history of two or more recurrent pregnancy losses, serum anticardiolipin and serum antiphospholipid were measured using ELISA method. The positive IgG anticardiolipin and IgG antiphospholipid were detected in 12. 34% (19 patients) and 6.5% (10 patients) of patients respectively. Although 16 out of 19 patients with positive IgG anticardiolipin were negative for IgG antiphospholipid and 7 out of 10 patients with positive IgG antiphosphplipid were negative IgG anticardiolipin, but there was a significant correlation between IgG anticardiolipin and IgG antiphaspholipid ( r = 0.222 p=0.000). Our data concluded that anticardiolipin antibody is found to be more important than anti phospholipid antibody in recurrent abortion.
Keywords: Anticardiolipin antibody, Antiphospholipid antibody, Recurrent abortion
Full-Text [PDF 40 kb]   (489 Downloads) |   |   Full-Text (HTML)  (389 Views)  
Type of Study: Original Article |
References
1. Tariverdian G, poul, M. Genetische diagnostic in Geburtshilf. Springer- verlag. Heidelberg 1999;191.
2. Klousek DK. Anatomical & chromosomal abnormalitic in specimens of early sportoneous aborthion. Seven years experience. Birth defects 1987; 23:153-168.
3. Velayuthaprabhu S, Archunan G. Evaluation of anticardiolipin antibodies and Antiphosphatidylserine antibodies in women with recurrent abortion. IJMS 2005;59:347-352. [DOI:10.4103/0019-5359.16651] [PMID]
4. Lockshin MD. Anitphospholipid antibody. J Am Med Assoc 1997; 277:1549-1551. [DOI:10.1001/jama.1997.03540430061034]
5. Kultech WH, Rote NS, Silver R. Antiphospholipid antibodies and Reproduction : the anti phospholipid antibodiy syndrome. Am J Reprod Immunology 1999;42:133-152. [DOI:10.1111/j.1600-0897.1999.tb00087.x] [PMID]
6. Takokuwa k, Asano k, Arakawa M, Yasuda M, Hasegawa I, Tanaka K. Chromosome analysis of aborted conceptuses of recurrent aborters positive for anticardiolipin antibody. Fertil Steril 1997;68:54-58. [DOI:10.1016/S0015-0282(97)81475-6]
7. Arakawa M, Takakuwa K, Honda K, Tamura M, Kurabayashi T, Tanaka K. Suppressive effect of anticardiolipin antibody an the praliferation of human umbilical vein endothelial cells. Fertil Steril 1999;71:1103-1107. [DOI:10.1016/S0015-0282(99)00117-X]
8. Yetman DL, Kutteh WH. Antiphospholipid antibody panels and recurrent pregnancy loss. Prevalence of cardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril 1996;66:540-546. [DOI:10.1016/S0015-0282(16)58565-3]
9. Rai RS. Antiphospholipid syndrome and recurrent miscarriage. J Postgrad Med 2002;48:3-4.
10. Ahlenius I, Floberg J, Thomassen P. Sixty-six cases of intrauterine fetal death: a prospective study with an extensive test pretocol. Acta Obstet Gynecol Scand 1995; 74:109-117. [DOI:10.3109/00016349509008917] [PMID]
11. Sugi T, Matsuboyashi H, Inmo A. Danl Makinat Anti phospholipid antibody in Recurrent early pregnancy loss and mild to late pregnany loss. J Obstost Gynaecol Res 2004;30:326-332. [DOI:10.1111/j.1447-0756.2004.00206.x] [PMID]
12. Mitiracui N, Bergi L, Hizem S, Nsiri B, Finan RR, Gris JC, et al. Prevalemce of antiphospholipid andibodies in early and lat recurrent pregmancy loss. Eur J Obstest Gynecol Report Biol 2005;119:164-70. [DOI:10.1016/j.ejogrb.2004.07.003] [PMID]
13. Haddow JE, Rote NS, Dostal-Johnson D, Palomaki GE, Pulkkinen AJ, Knight GJ. Lack of an association between late fetal death and antiphospholipid antidody measurements in the second trimester. Am J Obstet Gynecol 1991;165:1308-1312. [DOI:10.1016/0002-9378(91)90356-V]
14. Lynch A, Marlar R, Murphy J, Davila G, Santos M, Rutledge, et al. Antiphospholipid antibodies in predicting adverse prepnancy. A prospective study. Ann Intern Med 1994; 120: 470-475. [DOI:10.7326/0003-4819-120-6-199403150-00004] [PMID]
15. Kdous M, Horchi Cho R, Gallard G. Antiphospholipid antibodies and pregnancy. Tunis Med 2005;87:1-5.
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb